|This Slide: #56 of 100|
Slide #56. BioReference Laboratories, Inc. — Edge BioSystems' Service Business
BioReference Laboratories, Inc. (BRLI)
Edge BioSystems' Service Business
BioReference Laboratories, Inc. (Nasdaq:BRLI) announced today that it has entered into a definitive agreement for the acquisition of Edge BioSystems CLIA laboratory business and related assets ("Edge BioServ"), primarily a genetic sequencing service business located in Gaithersburg, MD.
Bio-Reference Laboratories is a clinical testing laboratory providing testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. Co. provides a list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. Co. mainly focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional health care. Co. also operates a clinical knowledge management service through its PSIMedica business unit, and operates a web-based connectivity portal application through its CareEvolve subsidiary.
Open the BRLI Page at The Online Investor »
Hold (2.00 out of 4)
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite